Premium
Agglutination by concanavalin A of normal chick embryo fibroblasts treated by 5‐bromodeoxyuridine (BrdU)
Author(s) -
Biquard JeanMichel
Publication year - 1974
Publication title -
journal of cellular physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.529
H-Index - 174
eISSN - 1097-4652
pISSN - 0021-9541
DOI - 10.1002/jcp.1040840313
Subject(s) - rous sarcoma virus , bromodeoxyuridine , concanavalin a , embryo , biology , transformation (genetics) , thymidine , microbiology and biotechnology , agglutination (biology) , virus , virology , immunology , cell growth , antibody , biochemistry , dna , in vitro , gene
When chick embryo fibroblasts are grown for two days in the presence of low doses (18 μg/ml) of 5‐bromodeoxyuridine (BrdU), their agglu‐tinability by Concanavalin A is increased to about the same degree as following viral transformation of the cells by Rous sarcoma virus. Simultaneous addition of a large excess, but not of a low dose of thymidine prevents this effect of BrdU. Treatment with BrdU also enhances the agglutinability of fibroblasts infected with a conditional It mutant of Rcus sarcoma virus at the temperature of 41° which restricts morphological transformation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom